Physician profile
Penninah Kumar
NPI 1477872083
$71,670.07
in general payments reported to CMS, 2019-2025
39 companies · $23K in 2025
The $23K reported for 2025 was more than what 98% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,733 · 2020: $835 · 2021: $1,653 · 2022: $2,755 · 2023: $14K · 2024: $22K · 2025: $23K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $38K · Food and Beverage: $9,458 · Travel and Lodging: $6,929 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $38,107.50 |
| Food and Beverage | $9,457.75 |
| Travel and Lodging | $6,928.90 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $47,197.93 | 2023-2025 | |
| Melinta Therapeutics, LLC | $7,929.69 | 2019-2025 | Kimyrsa, Rezzayo |
| Paratek Pharmaceuticals, INC. | $7,207.96 | 2019-2025 | Nuzyra |
| Smith+Nephew, INC. | $3,526.15 | 2019-2025 | Grafix, Grafix Pl, Stravix |
| Organogenesis INC. | $1,137.66 | 2021-2025 | Puraply, Puraply Wound Matrix, Novachor |
| Horizon Therapeutics Plc | $567.30 | 2019-2022 | |
| Orthofix Medical, INC. | $505.72 | 2019-2022 | |
| Abbvie INC. | $457.49 | 2021-2025 | |
| Triad Life Sciences INC. | $390.75 | 2022 | |
| Kerecis Limited | $256.28 | 2019-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Ani Pharmaceuticals, INC. | $254.95 | 2025 | Purified Cortrophin Gel |
| Bioventus LLC | $221.08 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Amgen INC. | $218.13 | 2024-2025 | Krystexxa |
| Mimedx Group, INC. | $200.98 | 2025 | |
| Lifenet Health | $197.45 | 2025 | Theragenesis Wound Matrix |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $176.69 | 2019-2020 | |
| Assertio Therapeutics, INC. | $147.81 | 2020 | |
| Averitas Pharma INC. | $142.29 | 2024-2025 | Qutenza |
| Progenacare Global, LLC | $139.90 | 2023 | |
| Osiris Therapeutics INC. | $113.02 | 2019 | |
| Stryker Corporation | $99.93 | 2019-2022 | |
| Acera Surgical, INC. | $74.54 | 2019-2025 | Restrata Wound Matrix |
| Nevro Corp. | $74.16 | 2022-2024 | Senza |
| Nabriva Therapeutics, Plc | $40.72 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $38.57 | 2019 | |
| Solventum Corporation | $36.83 | 2024-2025 | Activ.A.C., Promogran Prisma, 3m Cavilon |
| Alfasigma USA, INC. | $36.59 | 2021-2022 | |
| Aroa Biosurgery Incorporated | $34.10 | 2025 | |
| Surgenex LLC | $33.82 | 2025 | Ardeograft, Surmatrix, Pellograft |
| Abbott Laboratories | $33.72 | 2023-2024 | Octrode, Eterna |
| Ibsa Pharma INC. | $29.43 | 2023-2024 | Tirosint, Licart, Tirosint |
| Access Pro Medical, LLC | $24.78 | 2025 | Matriderm |
| Urgo Medical North America, LLC | $24.73 | 2024 | Urgoclean Ag |
| Djo, LLC | $19.51 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $19.34 | 2022 | |
| Medline Industries LP | $17.71 | 2022 | |
| Tactile Systems Technology INC | $14.89 | 2025 | Nimbl, Flexitouch Plus |
| Kci USA, INC. | $14.20 | 2019 | |
| Zimmer Biomet Holdings, INC. | $13.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Penninah Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.